Healthcare · Drug Manufacturers - General
Latest call day: 2026-10-23 · full consensus board · graded history
Price (daily close, 2026-10-23)
Trailing returns (daily closes)
Today's calls AI
| Biotech · Momentum Acceleration | UP 100% | Momentum Acceleration — trend speeding up. BIIB ranks #1 of 8 in Biotech (100% bullish percentile, signal +19.7%), so the agent calls it UP for the next session. |
| Biotech · Bollinger Reversion | DOWN 100% | Bollinger Reversion — fade moves outside the bands. BIIB ranks #3 of 8 in Biotech (100% bearish percentile), so the agent calls it DOWN for the next session. |
| Biotech · Breakout | UP 100% | Breakout — pushing above the prior channel high. BIIB ranks #1 of 8 in Biotech (100% bullish percentile, signal +4.4%), so the agent calls it UP for the next session. |
| Biotech · Mean-Reversion | DOWN 100% | Mean-Reversion — contrarian on the trailing return. BIIB ranks #3 of 8 in Biotech (100% bearish percentile, recent move +7.9%, fading it), so the agent calls it DOWN for the next session. |
| Biotech · Meta-Ensemble | UP 100% | Meta-Ensemble — a blend of this domain's strategies weighted by their recent precision. BIIB ranks #1 of 8 in Biotech (100% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · Momentum | UP 100% | Momentum — trailing return (trend-following). BIIB ranks #1 of 8 in Biotech (100% bullish percentile, signal +12.1%), so the agent calls it UP for the next session. |
| Biotech · Volume Thrust | UP 100% | Volume Thrust — volume-confirmed accumulation. BIIB ranks #1 of 8 in Biotech (100% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · Donchian | UP 86% | Donchian — position within the Donchian channel. BIIB ranks #2 of 8 in Biotech (86% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · 52-Week-High | UP 86% | 52-Week-High — proximity to the trailing high. BIIB ranks #2 of 8 in Biotech (86% bullish percentile, 100% of its 52-week high), so the agent calls it UP for the next session. |
| Biotech · LightGBM | UP 86% | LightGBM — a gradient-boosted model fit on this basket's recent features. BIIB ranks #2 of 8 in Biotech (86% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · MACD | UP 71% | MACD — MACD histogram momentum crossover. BIIB ranks #3 of 8 in Biotech (71% bullish percentile), so the agent calls it UP for the next session. |
Best agents on BIIB (graded record)
| Mean-Reversion Agent | 100% | 1/1 correct | UP |
| Biotech · Bollinger Reversion | 60% | 24/40 correct | DOWN |
| Biotech · Relative Strength | 53% | 8/15 correct | DOWN |
| Biotech · LightGBM | 52% | 26/50 correct | UP |
| Biotech · SOTA Ensemble | 50% | 28/56 correct | UP |
| Biotech · RSI Mean-Reversion | 50% | 12/24 correct | DOWN |
| Biotech · Vol-Adjusted Momentum | 50% | 4/8 correct | DOWN |
| Biotech · Low Volatility | 50% | 3/6 correct | UP |
| Biotech · Mean-Reversion | 49% | 17/35 correct | DOWN |
| Biotech · Dual Momentum | 48% | 14/29 correct | UP |
Recent news
| 2026-10-23 | Biogen (BIIB) Surges 5.3%: Is This an Indication of Further Gains? · yf_tkr_BIIB |
| 2026-10-22 | Biogen +5% on BofA Price Target Hike Ahead of “Relatively Quiet” Q3 · yf_tkr_BAC |
| 2026-10-22 | DHL Supply Chain and Biogen expand health logistics partnership in Türkiye · STAT Times |
| 2026-10-22 | BofA raises Biogen stock price target on pipeline potential · Investing.com |
| 2026-10-21 | Biogen Q3 Earnings Preview: Grounds For Optimism, But Disappointment The Norm · seeking_alpha |
| 2026-10-21 | Biogen shares may move 4.3% on Oct. 28 earnings release · Investing.com |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。